Intron Biotechnology Inc. (048530)
Market Open
15 Oct, 06:30 AM
KRX SM KRX SM Primary ₩
2,690. 00
-95
-3.4111%
₩
97.15B Market Cap
- P/E Ratio
400% Div Yield
114,833 Volume
- Eps
₩ 2,785
Previous Close Want to track 048530 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Intron Biotechnology Inc. (048530) Statistics
Valuation metrics
Market Cap 97.15B
Enterprise value 66.65B
Trailing P/E (ttm) -8.67
Forward P/E -
PEG ratio 0.15
Price/Sales (ttm) 12.13
Price/Book (mrq) 1.43
Enterprise Value/Revenue 9.2
Enterprise Value/EBITDA -7.68
Overview
Shares outstanding 30.89M
Float 24.53M
Shares short -
% Held by insiders 0.19%
% Held by institutions 0.01%
Average volume (10 days) 99.75K
Average volume (90 days) 79.09K
Price summary
52-Week low 2,250
52-Week high 7,010
Beta 0.15
50-Day moving average 2,830.94
200-Day moving average 2,988.51
Dividends and splits
Forward annual dividend rate 400
Forward annual dividend yield 0.1272%
Trailing annual dividend rate 100
Trailing annual dividend yield 0.0351%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 15 Apr 2026
Ex-Dividend Date 29 Dec 2025
Last split factor 2:1
Last split Date 10 Jan 2019
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -1.47%
Operating margin -1.09%
Operational effectiveness
Return on assets -0.16%
Return on equity -0.16%
Income Statement
Revenue (ttm) 5.74B
Revenue per share (ttm) 232.17
Quarterly revenue growth (yoy) 0.12%
Gross profit (ttm) 3.04B
EBITDA -5.96B
Net income to common (ttm) -8.96B
Diluted EPS (ttm) -340.84
Quarterly earnings growth (yoy) 0.59%
Balance Sheet
Total cash (mrq) 41.78B
Total cash per share (mrq) 1,165.18
Total debt (mrq) 3.35B
Total Debt/Equity (mrq) 0.08
Current ratio (mrq) 9.56%
Book value per share (mrq) 1,992.08
Cash Flow
Cash flow statement -5.21B
Levered free cash flow (LFCF) -5.37B
2026 © Marketlog. All Rights Reserved.
